IP Verse

Kraus & Weisert competitive analysis

Explore patent oppositions filed by Kraus & Weisert against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026

Patent Number	Title	Applicant	Opposition Date
EP3647783	Identifying Patient Response To S1P Receptor Modulator Administration	NOVARTIS	Sep 21, 2023
EP3597216	Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof	E R SQUIBB & SONS	May 19, 2023
EP2397142	Use Of Dpp Iv Inhibitors	BOEHRINGER INGELHEIM	Apr 25, 2023
EP2653873	Compositions And Uses For Treating Multiple Sclerosis	BIOGEN IDEC MA	Apr 19, 2023
EP3824053	Purification Of Recycled And Renewable Organic Material	NESTE OYJ	Mar 14, 2023
EP2986304	Pharmaceutical Composition, Methods For Treating And Uses Thereof	BOEHRINGER INGELHEIM	Oct 12, 2022
EP3351261	Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy	UNIVERSITT ZRICH	Mar 2, 2022
EP2902817	Optical Component And Method For Producing Same	NIKON ESSILOR	Aug 11, 2021
EP2139494	Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate	ASTRAZENECA	Dec 11, 2020
EP3038654	New Use	NOVARTIS	Jul 28, 2020

Discover the latest PTAB cases involving Kraus & Weisert, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Kraus & Weisert with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
KRAUS & WEISERT	13	-	-	-
BIOGEN IDEC MA	-	39	-	1
BOEHRINGER INGELHEIM	33	214	8	9
NOVARTIS	6	520	-	21